Pluri PLUR
NASDAQ PLUR
$1.71 -0.05 (-2.84%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pluri (PLUR) Cash & Equivalents (2010 - 2025)

Pluri (PLUR) posted quarterly Cash & Equivalents of $4.7 million for Q4 2025, down 35.12% year-over-year from $7.2 million in Q4 2024, and up 10.12% quarter-over-quarter from $4.3 million in Q3 2025.

Pluri (PLUR) Cash & Equivalents (2010 - 2025) Analysis & Trends

Pluri (PLUR) has reported Cash & Equivalents for 16 consecutive years, with $4.7 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash & Equivalents fell 35.12% year-over-year to $4.7 million; the TTM figure through Dec 2025 stood at $4.7 million (down 35.12% YoY), while the FY2025 annual figure was $5.9 million, down 13.09% from the prior year.
  • Cash & Equivalents advanced to $4.7 million in Q4 2025 per PLUR's latest filing, from $4.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $31.8 million in Q2 2021 and bottomed at $633000.0 in Q1 2023.
  • Historically, Cash & Equivalents has averaged $9.8 million across 5 years, with a median of $7.6 million in 2024.
  • Annual changes were most pronounced in 2021 — Cash & Equivalents soared 47955.0% — and 2023, when it sank 97.46%.
  • Pluri's Cash & Equivalents stood at $19.2 million in 2021, then plunged by 54.13% to $8.8 million in 2022, then plunged by 88.46% to $1.0 million in 2023, then soared by 610.12% to $7.2 million in 2024, then sank by 35.12% to $4.7 million in 2025.
  • Business Quant data shows PLUR's Cash & Equivalents at $4.7 million in Q4 2025, $4.3 million in Q3 2025, and $5.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Pluri 16.21 Mn 3.72 Mn 86,000.00 4.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.69 Mn
Sep 30, 2025 4.26 Mn
Jun 30, 2025 5.90 Mn
Mar 31, 2025 8.50 Mn
Dec 31, 2024 7.23 Mn
Sep 30, 2024 3.20 Mn
Jun 30, 2024 6.78 Mn
Mar 31, 2024 7.99 Mn
Dec 31, 2023 1.02 Mn
Sep 30, 2023 5.25 Mn
Jun 30, 2023 6.26 Mn
Mar 31, 2023 633,000.00
Dec 31, 2022 8.82 Mn
Sep 30, 2022 10.03 Mn
Jun 30, 2022 11.41 Mn
Mar 31, 2022 24.93 Mn
Dec 31, 2021 19.22 Mn
Sep 30, 2021 15.22 Mn
Jun 30, 2021 31.84 Mn
Mar 31, 2021 12.27 Mn